FOXO1 and metabolic dysfunction-associated steatohepatitis: We then subjected liver biopsies to anti-FOXO1 and anti-F4/80 immunohistochemistry, revealing that FOXO1 protein levels were increased in hepatic macrophages in the liver of patients with NASH (Figure 9, E and F).